Perioperative Management for Functional Ganglioneuroma in a 2-Year-Old Child with Multiple Congenital Defects and COVID-19: A Case Report
- PMID: 35775802
- PMCID: PMC9629191
- DOI: 10.5152/TJAR.2021.21422
Perioperative Management for Functional Ganglioneuroma in a 2-Year-Old Child with Multiple Congenital Defects and COVID-19: A Case Report
Abstract
Unlike neuroblastoma, ganglioneuroma is a rare entity in children younger than 7 years of age. Further, these tumors are mostly inactive endocrinologically with the symptoms of abdominal pain or palpable mass. Unfortunately, when functional, they mimic or occasionally coexist with pheochromocytoma. While perioperative management of pheochromocytoma has evolved, very little is known regarding the periopera- tive management of functioning ganglioneuroma. Hormone secretion due to surgical manipulation and anaesthesia leads to life-threatening complications. The risk further increases when associated with other congenital comorbidities. Furthermore, the corona pandemic, in other words, coronavirus disease 2019 infection, in the perioperative period is another new challenge. We report perioperative management and outcome of a functioning retroperitoneal ganglioneuroma in a 2-year-old child, having a ventricular septal defect, spina bifida occulta, and coronavirus disease 2019. The case also highlights decision-making challenges during the coronavirus disease 2019 pandemic.
Figures
References
-
- ACS/Australian Society of Anaesthetists/Association of Operating Room Nurses/Australian Historical Association. Joint statement: roadmap for maintaining essential surgery during COVID-19 pandemic; 2020. Available at: https://www.facs.org/covid-19/clinical-guidance/nov2020-roadmap. Accessed January 25, 2021.
LinkOut - more resources
Full Text Sources